John Mrugal, Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 1425 Shoemaker Ave, West Wyoming, PA 18644 Phone: 570-718-1996 Fax: 570-718-1997 |
News Archive
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has completed the treatment portion, including all protocol-allowed retreatments of all patients, of its Phase 2 clinical trial of PV-10 for metastatic melanoma. The study involved treatment of 80 subjects with Stage III or Stage IV metastatic melanoma.
Young people who conform most strongly to norms of masculinity and femininity-the most "feminine" girls and the most "masculine" boys-are significantly more likely than their peers to engage in behaviors that pose cancer risks, according to a new study led by Harvard School of Public Health (HSPH) researchers.
A three decade long study has proven that oral contraceptive pills may alleviate painful periods for some women. Estimates suggest more than half of women have suffered from the condition, called dysmenorrhea, at some point.
The Food and Drug Administration (FDA) has approved the first DNA-based blood test to help detect cystic fibrosis. The Tag-It Cystic Fibrosis Kit directly analyzes human DNA to find genetic variations indicative of the disease. The test will be used to help diagnose cystic fibrosis in children and to identify adults who are "carriers" of the gene variations.
Roche announced today that the cobas TaqScreen MPX Test, version 2.0 for use on the cobas s 201 system is now commercially available in Europe.
› Verified 3 days ago